Inhibition of Marek's disease virus replication by retroviral vector-based RNA interference

Virology. 2008 Aug 1;377(2):265-72. doi: 10.1016/j.virol.2008.03.019.

Abstract

RNA interference (RNAi) is a promising antiviral methodology. We recently demonstrated that retroviral vectors expressing short-hairpin RNAs (shRNA-mirs) in the context of a modified endogenous micro-RNA (miRNA) can be effective in reducing replication of other retroviruses in chicken cells. In this study, similar RNAi vectors are shown to inhibit replication of the avian herpesvirus, Marek's disease virus (MDV, also known as gallid herpesvirus type 2), and its close relative, herpesvirus of turkeys (HVT). Cells expressing shRNA-mirs targeting the MDV or HVT gB glycoprotein gene or the ICP4 transcriptional regulatory gene show significant inhibition of viral replication. Not only are viral titers reduced, but observed plaque sizes are significantly smaller when the virus is grown on cells in which RNAi is effective. We also describe a modified retroviral delivery vector that expresses a shRNA-mir containing up to three RNAi target sequences and employ this vector with multiple targets within the MDV gB gene or within both the gB and ICP4 genes. The use of targets within multiple genes potentially can provide a larger antiviral effect and/or make it more difficult for viral escape mutations to evolve.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Avian Leukosis Virus / drug effects*
  • Genetic Vectors
  • Marek Disease / prevention & control
  • Marek Disease / virology
  • MicroRNAs / pharmacology*
  • RNA Interference*
  • Retroviridae / genetics
  • Retroviridae / metabolism*
  • Viral Plaque Assay / veterinary
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*
  • Virus Replication / drug effects*
  • Virus Replication / physiology

Substances

  • MicroRNAs
  • Viral Proteins